| Year |
Citation |
Score |
| 2023 |
Blatter M, Meylan C, Cléry A, Giambruno R, Nikolaev Y, Heidecker M, Solanki JA, Diaz MO, Gabellini D, Allain FH. RNA binding induces an allosteric switch in Cyp33 to repress MLL1-mediated transcription. Science Advances. 9: eadf5330. PMID 37075125 DOI: 10.1126/sciadv.adf5330 |
0.609 |
|
| 2019 |
Berg S, Diaz MO, Nand S, Zhang J. Germline Mutations Predispose to Familial Myeloproliferative Neoplasms Blood. 134: 2969-2969. DOI: 10.1182/Blood-2019-124805 |
0.332 |
|
| 2012 |
Shih SJ, Fass J, Buffalo V, Lin D, Singh SP, Diaz MO, Vaughan AT. Multiple clonal MLL fusions in a patient receiving CHOP-based chemotherapy British Journal of Haematology. 159: 50-57. PMID 22845170 DOI: 10.1111/J.1365-2141.2012.09248.X |
0.337 |
|
| 2012 |
Chauhan C, Zraly CB, Parilla M, Diaz MO, Dingwall AK. Histone recognition and nuclear receptor co-activator functions of Drosophila cara mitad, a homolog of the N-terminal portion of mammalian MLL2 and MLL3. Development (Cambridge, England). 139: 1997-2008. PMID 22569554 DOI: 10.1242/Dev.076687 |
0.452 |
|
| 2012 |
Poppen S, Diaz M. Abstract 4034: The role of CYP33 in MLL target gene repression Cancer Research. 72: 4034-4034. DOI: 10.1158/1538-7445.Am2012-4034 |
0.709 |
|
| 2011 |
Ho BT, Shih S, Singh SP, Diaz MO, Lin D, Buffalo V, Fass J, Vaughan AT. Clonal MLL Fusions with a Signature of Activation Induced Cytidine Deaminase Activity, Blood. 118: 3444-3444. DOI: 10.1182/Blood.V118.21.3444.3444 |
0.337 |
|
| 2010 |
Park S, Osmers U, Raman G, Schwantes RH, Diaz MO, Bushweller JH. The PHD3 domain of MLL acts as a CYP33-regulated switch between MLL-mediated activation and repression . Biochemistry. 49: 6576-86. PMID 20677832 DOI: 10.1021/Bi1009387 |
0.495 |
|
| 2009 |
Tie F, Banerjee R, Stratton CA, Prasad-Sinha J, Stepanik V, Zlobin A, Diaz MO, Scacheri PC, Harte PJ. CBP-mediated acetylation of histone H3 lysine 27 antagonizes Drosophila Polycomb silencing. Development (Cambridge, England). 136: 3131-41. PMID 19700617 DOI: 10.1242/Dev.037127 |
0.422 |
|
| 2009 |
Le H, Singh S, Shih SJ, Du N, Schnyder S, Loredo GA, Bien C, Michaelis L, Toor A, Diaz MO, Vaughan AT. Rearrangements of the MLL gene are influenced by DNA secondary structure, potentially mediated by topoisomerase II binding. Genes, Chromosomes & Cancer. 48: 806-15. PMID 19530238 DOI: 10.1182/Blood.V112.11.3105.3105 |
0.318 |
|
| 2008 |
Chen J, Santillan DA, Koonce M, Wei W, Luo R, Thirman MJ, Zeleznik-Le NJ, Diaz MO. Loss of MLL PHD finger 3 is necessary for MLL-ENL-induced hematopoietic stem cell immortalization. Cancer Research. 68: 6199-207. PMID 18676843 DOI: 10.1158/0008-5472.Can-07-6514 |
0.708 |
|
| 2008 |
Tang M, Wei X, Guo Y, Breslin P, Zhang S, Zhang S, Wei W, Xia Z, Diaz M, Akira S, Zhang J. TAK1 is required for the survival of hematopoietic cells and hepatocytes in mice. The Journal of Experimental Medicine. 205: 1611-9. PMID 18573910 DOI: 10.1084/Jem.20080297 |
0.309 |
|
| 2008 |
Erfurth FE, Popovic R, Grembecka J, Cierpicki T, Theisler C, Xia ZB, Stuart T, Diaz MO, Bushweller JH, Zeleznik-Le NJ. MLL protects CpG clusters from methylation within the Hoxa9 gene, maintaining transcript expression. Proceedings of the National Academy of Sciences of the United States of America. 105: 7517-22. PMID 18483194 DOI: 10.1073/Pnas.0800090105 |
0.379 |
|
| 2005 |
Betti CJ, Villalobos MJ, Jiang Q, Cline E, Diaz MO, Loredo G, Vaughan AT. Cleavage of the MLL gene by activators of apoptosis is independent of topoisomerase II activity. Leukemia. 19: 2289-95. PMID 16193084 DOI: 10.1038/Sj.Leu.2403966 |
0.35 |
|
| 2005 |
Xia ZB, Popovic R, Chen J, Theisler C, Stuart T, Santillan DA, Erfurth F, Diaz MO, Zeleznik-Le NJ. The MLL fusion gene, MLL-AF4, regulates cyclin-dependent kinase inhibitor CDKN1B (p27kip1) expression. Proceedings of the National Academy of Sciences of the United States of America. 102: 14028-33. PMID 16169901 DOI: 10.1073/Pnas.0506464102 |
0.423 |
|
| 2005 |
Vaughan AT, Betti CJ, Villalobos MJ, Premkumar K, Cline E, Jiang Q, Diaz MO. Surviving apoptosis: A possible mechanism of benzene-induced leukemia Chemico-Biological Interactions. 153: 179-185. PMID 15935815 DOI: 10.1016/J.Cbi.2005.03.022 |
0.323 |
|
| 2004 |
Diaz MO, Koonce MA. Cyp33-MLL Interaction Modulates Human HOX Gene Expression and Chromatin Structure. Blood. 104: 1127-1127. DOI: 10.1182/Blood.V104.11.1127.1127 |
0.472 |
|
| 2003 |
Xia ZB, Anderson M, Diaz MO, Zeleznik-Le NJ. MLL repression domain interacts with histone deacetylases, the polycomb group proteins HPC2 and BMI-1, and the corepressor C-terminal-binding protein. Proceedings of the National Academy of Sciences of the United States of America. 100: 8342-7. PMID 12829790 DOI: 10.1073/Pnas.1436338100 |
0.451 |
|
| 2002 |
Anderson M, Fair K, Amero S, Nelson S, Harte PJ, Diaz MO. A new family of cyclophilins with an RNA recognition motif that interact with members of the trx/MLL protein family in Drosophila and human cells. Development Genes and Evolution. 212: 107-13. PMID 11976948 DOI: 10.1007/S00427-002-0213-8 |
0.737 |
|
| 2001 |
Fair K, Anderson M, Bulanova E, Mi H, Tropschug M, Diaz MO. Protein interactions of the MLL PHD fingers modulate MLL target gene regulation in human cells. Molecular and Cellular Biology. 21: 3589-97. PMID 11313484 DOI: 10.1128/Mcb.21.10.3589-3597.2001 |
0.761 |
|
| 2000 |
Nickoloff BJ, Chaturvedi V, Bacon P, Qin JZ, Denning MF, Diaz MO. Id-1 delays senescence but does not immortalize keratinocytes Journal of Biological Chemistry. 275: 27501-27504. PMID 10908559 DOI: 10.1074/Jbc.C000311200 |
0.3 |
|
| 1999 |
Fitzgerald KT, Diaz MO. MLL2: A new mammalian member of the trx/MLL family of genes Genomics. 59: 187-192. PMID 10409430 DOI: 10.1006/Geno.1999.5860 |
0.362 |
|
| 1998 |
Koeneman KS, Pan CX, Jin JK, Pyle JM, Flanigan RC, Shankey TV, Diaz MO. Telomerase activity, telomere length, and DNA ploidy in prostatic intraepithelial neoplasia (PIN). The Journal of Urology. 160: 1533-9. PMID 9751408 DOI: 10.1016/S0022-5347(01)62608-9 |
0.452 |
|
| 1997 |
Super HG, Strissel PL, Sobulo OM, Burian D, Reshmi SC, Roe B, Zeleznik-Le NJ, Diaz MO, Rowley JD. Identification of complex genomic breakpoint junctions in the t(9;11) MLL-AF9 fusion gene in acute leukemia Genes Chromosomes and Cancer. 20: 185-195. PMID 9331569 DOI: 10.1002/(Sici)1098-2264(199710)20:2<185::Aid-Gcc9>3.0.Co;2-# |
0.315 |
|
| 1997 |
Pan C, Xue BH, Ellis TM, Peace DJ, Díaz MO. Changes in telomerase activity and telomere length during human T lymphocyte senescence. Experimental Cell Research. 231: 346-53. PMID 9087176 DOI: 10.1006/Excr.1997.3475 |
0.445 |
|
| 1996 |
Díaz MO, Testa D. Type I interferon genes and proteins Biotherapy. 8: 157-162. PMID 8813327 DOI: 10.1007/Bf01877200 |
0.334 |
|
| 1996 |
Jagasia AA, Block JA, Qureshi A, Diaz MO, Nobori T, Gitelis S, Iyer AP. Chromosome 9 related aberrations and deletions of the CDKN2 and MTS2 putative tumor suppressor genes in human chondrosarcomas. Cancer Letters. 105: 91-103. PMID 8689637 DOI: 10.1016/0304-3835(96)04274-7 |
0.332 |
|
| 1996 |
Jagasia AA, Block JA, Diaz MO, Nobori T, Gitelis S, Inerot SE, Iyer AP. Partial deletions of the CDKN2 and MTS2 putative tumor suppressor genes in a myxoid chondrosarcoma. Cancer Letters. 105: 77-90. PMID 8689636 DOI: 10.1016/0304-3835(96)04273-5 |
0.333 |
|
| 1995 |
Mbangkollo D, Burnett R, McCabe N, Thirman M, Gill H, Yu H, Rowley JD, Diaz MO. The human MLL gene: Nucleotide sequence, homology to the Drosophila trx zinc-finger domain, and alternative splicing Dna and Cell Biology. 14: 475-483. PMID 7598802 DOI: 10.1089/Dna.1995.14.475 |
0.333 |
|
| 1995 |
Larripa I, Giere I, Slavutsky I, Diaz M. Molecular Study Of The Interferon Genes In Chronic Myeloid Leukemia Leukemia Research. 19: 513-517. PMID 7544849 DOI: 10.1016/0145-2126(95)00010-L |
0.332 |
|
| 1992 |
Wagner AJ, Le Beau MM, Diaz MO, Hay N. Expression, regulation, and chromosomal localization of the Max gene Proceedings of the National Academy of Sciences of the United States of America. 89: 3111-3115. PMID 1557420 |
0.31 |
|
| Show low-probability matches. |